NEPH
Price:
$3.58
Market Cap:
$38.87M
Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreatio...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2004-09-21
Stock Exchange
NASDAQ
Ticker
NEPH
According to Nephros, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 59.67. This represents a change of -31.82% compared to the average of 87.51 of the last 4 quarters.
The mean historical PE Ratio of Nephros, Inc. over the last ten years is 13.00. The current 59.67 PE Ratio has changed 45.81% with respect to the historical average. Over the past ten years (40 quarters), NEPH's PE Ratio was at its highest in in the December 2025 quarter at 210.34. The PE Ratio was at its lowest in in the December 2019 quarter at -104.08.
Average
13.00
Median
-12.33
Minimum
-28.93
Maximum
210.00
Discovering the peaks and valleys of Nephros, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.33%
Maximum Annual PE Ratio = 210.00
Minimum Annual Increase = -1010.40%
Minimum Annual PE Ratio = -28.93
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 44.36 | -78.87% |
| 2024 | 210.00 | -1010.40% |
| 2023 | -23.07 | 1.33% |
| 2022 | -1.61 | -88.80% |
| 2021 | -14.39 | -12.79% |
| 2020 | -16.50 | -30.35% |
| 2019 | -23.69 | 130.90% |
| 2018 | -10.26 | -64.53% |
| 2017 | -28.93 | 386.49% |
| 2016 | -5.95 | 140.26% |
The current PE Ratio of Nephros, Inc. (NEPH) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
77.10
5-year avg
43.06
10-year avg
13.00
Nephros, Inc.’s PE Ratio is greater than Daxor Corporation (5.77), greater than HeartBeam, Inc. (-0.87), greater than OneMedNet Corporation (-13.31), greater than ImmuCell Corporation (-179.77), greater than OS Therapies Incorporated (-1.50), greater than Jin Medical International Ltd. (14.93), greater than Outlook Therapeutics, Inc. (-0.75), greater than NRx Pharmaceuticals, Inc. (-2.38), greater than Spruce Biosciences, Inc. (-1.24), greater than Werewolf Therapeutics, Inc. (-0.55),
| Company | PE Ratio | Market cap |
|---|---|---|
| 5.77 | $61.18M | |
| -0.87 | $17.18M | |
| -13.31 | $36.76M | |
| -179.77 | $97.25M | |
| -1.50 | $72.86M | |
| 14.93 | $17.30M | |
| -0.75 | $124.49M | |
| -2.38 | $52.81M | |
| -1.24 | $63.95M | |
| -0.55 | $19.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nephros, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nephros, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nephros, Inc.'s PE Ratio?
How is the PE Ratio calculated for Nephros, Inc. (NEPH)?
What is the highest PE Ratio for Nephros, Inc. (NEPH)?
What is the 3-year average PE Ratio for Nephros, Inc. (NEPH)?
What is the 5-year average PE Ratio for Nephros, Inc. (NEPH)?
How does the current PE Ratio for Nephros, Inc. (NEPH) compare to its historical average?